Safety Data Review Across published studies, CJC-1295 has demonstrated a favorable safety profile: Common Adverse Events Injection site reactions (redness, swelling, pain): the most frequently reported side effect Headache: mild and transient Diarrhea: reported in some subjects, particularly at higher doses Flushing: transient warmth or redness Dizziness: occasional and brief Serious Adverse Events One serious adverse event in the early clinical development program, a death that occurred in a subject during a study, drew attention
Wang, X., He, G., Mai, K., Xu, W
Pregnant, breastfeeding, or kidney/liver patients should avoid this treatment
The use of Liquid Technology increases the speed of absorption of the preparation's unique ingredients
33 Large prospective studies are needed to replicate these preliminary findings and to confirm optimum dosing of zinc sulfate